Vor Biopharma (VOR) Retained Earnings (2020 - 2026)
Vor Biopharma (VOR) reported Retained Earnings of -$706000.0 for Q1 2026, up 99.86% year-over-year from -$353254.7 in Q1 2025, and down 1821.95% quarter-over-quarter from $41000.0 in Q4 2025.
Vor Biopharma (VOR) Retained Earnings (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has 7 years of Retained Earnings data on file, last reported at -$706000.0 in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$706000.0, up 99.86% year-over-year; the trailing twelve-month figure through Mar 2026 was -$706000.0 (up 99.86% YoY), and the FY2025 annual result was $41000.0, up 86.36% from the prior year.
- Retained Earnings declined to -$706000.0 in Q1 2026 per VOR's latest filing, from $41000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $41000.0 in Q4 2025 and troughed at -$2.9 billion in Q3 2025.
- A 5-year average of -$448.1 million and a median of -$250.6 million in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings soared 100.01% in 2024, then slumped 562543.68% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$770000.0 in 2022, then plunged by 44066.23% to -$340.1 million in 2023, then soared by 100.01% to $22000.0 in 2024, then soared by 86.36% to $41000.0 in 2025, then slumped by 1821.95% to -$706000.0 in 2026.
- Business Quant data shows VOR's Retained Earnings at -$706000.0 in Q1 2026, $41000.0 in Q4 2025, and -$2.9 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Vor Biopharma | 627.54 Mn | 627.54 Mn | - | -706,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -706,000.00 |
| Dec 31, 2025 | 41,000.00 |
| Sep 30, 2025 | -2.88 Bn |
| Jun 30, 2025 | -2.06 Bn |
| Mar 31, 2025 | -489.50 Mn |
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | -426.28 Mn |
| Jun 30, 2024 | -398.70 Mn |
| Mar 31, 2024 | -87,000.00 |
| Dec 31, 2023 | -340.08 Mn |
| Sep 30, 2023 | -313.82 Mn |
| Jun 30, 2023 | -280.63 Mn |
| Mar 31, 2023 | -250.65 Mn |
| Dec 31, 2022 | -770,000.00 |
| Sep 30, 2022 | -1.18 Mn |
| Jun 30, 2022 | -174.52 Mn |
| Mar 31, 2022 | -1.07 Mn |
| Dec 31, 2021 | -130.12 Mn |
| Sep 30, 2021 | -111.87 Mn |
| Jun 30, 2021 | -93.32 Mn |